The role of radioactive iodine in the treatment of Hürthle cell carcinoma of the thyroid

Thyroid

Volumn 13, Issue 6, 2003, Pages 577-584

  Besic, Nikola ^a   Vidergar Kralj, Barbara ^a   Frkovic Grazio, Snjezana ^a   Movrin Stanovnik, Tadeja ^a   Auersperg, Marija ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROID HORMONE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HURTHLE CELL THYROID CARCINOMA; MALE; PRIORITY JOURNAL; THYROID FOLLICULAR CARCINOMA; THYROID SURGERY; TREATMENT OUTCOME; WHOLE BODY SCINTISCANNING;

EID: 0037830533     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072503322238845     Document Type: Article

References (26)

1. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T 1987 Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am J Med 83:479-488.
2. Watson RG, Brennan MD, Goellner JR, van Heerden JA, McConahey WM, Taylor WF 1984 Invasive Hürthle cell carcinoma of the thyroid: natural history and management. Mayo Clin Proc 59:851-855.
3. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG 1992 The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714-720.
4. Grossman RF, Clark OH 1997 Hürthle cell carcinoma. Cancer Control 4:13-17.
5. Shaha AR, Shah JP, Loree TR 1996 Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg 172:692-694.
6. Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J 1991 Follicular Hürthle cell tumors of the thyroid gland. Cancer 68:1944-1953.
7. Sugino K, Ito K, Mimura K, Iwasaki H, It K 2001 Hürthle cell tumor of the thyroid: Analysis of 188 cases. World J Surg 25:1160-1163.
8. McDonald MP, Sanders LE, Silverman ML, Chan HS, Buyske J 1996 Hürthle cell carcinoma of the thyroid gland: Prognostic factors and results of surgical treatment. Surgery 120:1000-1004.
9. Besic N, Auersperg M, Golouh R 1999 Prognostic factors in follicular carcinoma of the thyroid - A multivariate survival analysis. Eur J Surg Oncol 25:599-605.
10. Sanders LE, Silverman M 1998 Follicular and Hurthle cell carcinoma: predicting outcome and directing therapy. Surgery 124:967-974.
11. Goldstein NS, Czako P, Neill JS 2000 Metastatic minimally invasive (encapsulated) follicular and Hürthle cell thyroid carcinoma: a study of 34 patients. Mod Pathol 13:123-130.
12. Khafif A, Khafif RA, Attie JN 1999 Hürthle cell carcinoma: A malignancy of low-grade potential. Head Neck 21:506-511.
13. Hedinger C, Williams ED, Sobin LH 1989 The WHO histological classification of thyroid tumors: A commentary on the second edition. Cancer 63:908-911.
14. Cooper DS, Schneyer CR 1990 Follicular and Hürthle cell carcinoma of the thyroid. Endocrinol Metab Clin North Am 19:577-591.
15. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA 1988 Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 67:501-508.
16. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C 1996 Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37:598-605.
17. Shaha AR, Loree TR, Shah JP 1995 Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118:1131-1136.
18. Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM 1991 Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 66:11-22.
19. Schlumberger M, Pacini F 1999 Initial treatment. In: Schlumberger M, Pacini F (eds) Thyroid Tumors. Editions Nucleon, Paris, pp 107-131.
20. Caplan RH, Abellera RM, Kisken WA 1994 Hürthle cell neoplasms of the thyroid gland: Reassessment of functional capacity. Thyroid 4:243-248.
21. Har-El G, Hadar T, Segal K, Levy R, Sidi J 1986 Hürthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer 57:1613-1617.
22. Goldman ND, Coniglio JU, Falk SA 1996 Thyroid cancers. I. Papillary, follicular, and Hürthle cell. Otolaryngol Clin North Am 29:593-609.
23. Samaan NA, Schultz PN, Haynie TP, Ordonez NG 1985 Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 60:376-380.
24. McHenry CR, Sandoval BA 1998 Management of follicular and Hürthle cell neoplasms of the thyroid gland. Surg Oncol Clin North Am 7:893-910.
25. Rosal J 1992 Tumors with oncocytic features (Hürthle cell tumors). In: Rosai J, Carcangiu ML, Delellis RA (eds) Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC, pp 161-182.
26. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG 2000 New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 3:205-216.